Jean-Philippe Pin Selected Research

Jean-Philippe Pin Research Topics

Disease

6	Brain Diseases (Brain Disorder) 01/2023 - 04/2012
6	Parkinson Disease (Parkinson's Disease) 01/2020 - 02/2002
5	Pain (Aches) 01/2018 - 02/2002
4	Neoplasms (Cancer) 01/2024 - 01/2019
3	Chronic Pain 10/2017 - 11/2013
3	Catalepsy 04/2012 - 07/2007
2	Autistic Disorder (Autism) 01/2022 - 01/2018
2	Neuralgia (Stump Neuralgia) 12/2018 - 07/2008
2	Hyperalgesia 01/2017 - 07/2008
2	Parkinsonian Disorders (Parkinsonism) 01/2015 - 10/2009
2	Kallmann Syndrome (Kallmann's Syndrome) 08/2014 - 01/2009
2	Nervous System Diseases (Neurological Disorders) 06/2012 - 02/2002
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 05/2024
1	Epilepsy (Aura) 05/2024
1	Brain Neoplasms (Brain Tumor) 01/2023
1	Central Nervous System Diseases (CNS Diseases) 01/2023
1	Type I Syndactyly 01/2023
1	Dyskinesias (Dyskinesia) 01/2020
1	Infections 12/2019
1	Osteosarcoma (Osteogenic Sarcoma) 11/2019
1	Glaucoma 01/2019
1	Hypersensitivity (Allergy) 11/2013
1	Anxiety Disorders (Anxiety Disorder) 05/2010
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2010
1	Movement Disorders (Movement Disorder) 05/2009
1	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2009
1	Anosmia 01/2009
1	Inflammation (Inflammations) 07/2008
1	Pathologic Processes 07/2005
1	Substance-Related Disorders (Drug Abuse) 02/2002

Drug/Important Bio-Agent (IBA)

8	Glutamic Acid (Glutamate)FDA Link 01/2023 - 04/2009
7	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2021 - 07/2008
4	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2021 - 07/2005
3	Haloperidol (Haldol)FDA LinkGeneric 04/2012 - 07/2007
2	Neurotransmitter Agents (Neurotransmitter)IBA 05/2024 - 01/2023
2	Anticonvulsants (Antiepileptic Drugs)IBA 01/2022 - 02/2002
2	Dopamine (Intropin)FDA LinkGeneric 01/2020 - 01/2015
2	Levodopa (L Dopa)FDA LinkGeneric 01/2020 - 10/2009
2	GABA-B ReceptorsIBA 06/2012 - 01/2010
2	gamma-Aminobutyric Acid (GABA)IBA 05/2009 - 04/2009
1	ErbB Receptors (EGF Receptor)IBA 01/2024
1	Monoclonal AntibodiesIBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	AntibodiesIBA 01/2023
1	glutathione-bicarbonate-Ringer solution (BSS plus)FDA LinkGeneric 01/2023
1	Peptides (Polypeptides)IBA 01/2023
1	Amino Acids FDA Link 01/2023
1	A 17 (A-17)IBA 01/2023
1	sodium bromideIBA 01/2022
1	BromidesIBA 01/2022
1	IonsIBA 01/2022
1	Tyrosine (L-Tyrosine)FDA Link 11/2021
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 11/2021
1	Protein Isoforms (Isoforms)IBA 11/2021
1	Neurotransmitter Receptors (Neurotransmitter Receptor)IBA 11/2021
1	GTP-Binding Proteins (G-Protein)IBA 01/2021
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2020
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2020
1	Chemokine ReceptorsIBA 12/2019
1	CXCR ReceptorsIBA 12/2019
1	CytokinesIBA 11/2019
1	Conditioned Culture MediaIBA 11/2019
1	Neutralizing AntibodiesIBA 11/2019
1	Interleukin-12 (IL 12)IBA 11/2019
1	OsteocalcinIBA 01/2019
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2018
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2017
1	OptoGluNAM4.1IBA 01/2016
1	LSP4-2022IBA 01/2016
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2015
1	Adrenocorticotropic Hormone (ACTH)FDA Link 05/2010
1	Serotonin ReceptorsIBA 05/2010
1	metabotropic glutamate receptor 4IBA 10/2009
1	LSP1 2111IBA 10/2009
1	GABA Receptors (GABA Receptor)IBA 04/2009
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2009
1	Vincristine (Oncovin)FDA LinkGeneric 07/2008
1	Formaldehyde (Formol)FDA Link 07/2008
1	CarrageenanIBA 07/2008
1	1-aminocyclopentane-1,3,4-tricarboxylic acidIBA 07/2008

Therapy/Procedure

5	Therapeutics 01/2023 - 02/2002
1	Analgesia 11/2017
1	Drug Therapy (Chemotherapy) 01/2017
1	Palliative Care (Palliative Therapy) 10/2009
1	Spinal Injections 07/2008